The approval of water soluble Aivlosin® for swine respiratory disease is very encouraging and in line with expectations. The approval strengthens the group’s offering in the US where Aivlosin® was first approved in 2012 in a water soluble formulation for the treatment of enteric disease of swine and later approved (for the same disease in swine) in 2016 in a premix formulation. North America represented 19% of Aivlosin® sales in FY 2017 and is a key territory for driving growth. ECO Animal Healt ....
24 Jul 2017
N+1 Singer - ECO Animal Health Group - Marketing authorisation for Aivlosin® in the US: a key growth territory
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
N+1 Singer - ECO Animal Health Group - Marketing authorisation for Aivlosin® in the US: a key growth territory
ECO Animal Health Group plc (EAH:LON) | 102 8.7 9.0% | Mkt Cap: 69.4m
- Published:
24 Jul 2017 -
Author:
Sheena Berry -
Pages:
3
The approval of water soluble Aivlosin® for swine respiratory disease is very encouraging and in line with expectations. The approval strengthens the group’s offering in the US where Aivlosin® was first approved in 2012 in a water soluble formulation for the treatment of enteric disease of swine and later approved (for the same disease in swine) in 2016 in a premix formulation. North America represented 19% of Aivlosin® sales in FY 2017 and is a key territory for driving growth. ECO Animal Healt ....